FindTrial
Sign In

Treatment of Ebola virus disease with TCM: a prospective clinical study

Treatment of Ebola virus disease with TCM: a prospective clinical study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-14005558
Enrollment
Unknown
Registered
2014-11-21
Start date
2014-11-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ebola virus disease

Interventions

test group :Qingwenbaidu decoction plus Xuebijing Injection plus symptomatic treatments
control group :Symptomatic treatments with western medicine

Sponsors

302 Military Hospital of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. To be aged 18 to 65 years; 2. Consistent with the diagnostic criteria of Ebola virus disease at early stage; 3. patients who must be voluntary to the trail and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Cardiac function, renal function, liver function is seriously unnormal; 2. Be diagnosed with Mental disorders; 3. The women during pregnancy or lactation; 4. Be diagnosed with other infectious diseases; 5. Poor adherence; 6. Deaths in 24 hours after admission.

Design outcomes

Primary

MeasureTime frame
Mortality;—

Secondary

MeasureTime frame
Effective rate;Temperature;—

Countries

Sierra Leone

Contacts

Public ContactXiaohe Xiao
pharmacy302@126.com+86 13911583851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026